Tema Oncology ETF (CANC) Holdings → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free CANC Stock Alerts $26.75 +0.02 (+0.07%) (As of 05/31/2024 ET) Add Compare Share Share HoldingsStock AnalysisChartDividendHoldingsRatingsTrendsStock AnalysisChartDividendHoldingsRatingsTrends Top 50 CANC HoldingsRankCompanyCurrent PriceWeightShares Held1REGNRegeneron Pharmaceuticals$980.16+1.1%5.73%1,0812MRKMerck & Co., Inc.$125.54+0.8%5.47%7,7233AstraZeneca PLCN/A4.90%5,7594Daiichi Sankyo Co LtdN/A4.25%22,9085AMGNAmgen$305.85+1.6%3.37%2,0356Novartis AG Registered SharesN/A3.10%5,648 Get the Latest News and Ratings for CANC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Oncology ETF and its competitors with MarketBeat's FREE daily newsletter. 7MRNAModerna$142.55-5.9%3.01%3,3998ILMNIllumina$104.28+3.2%2.95%5,1589BPMCBlueprint Medicines$105.56-0.8%2.88%5,20910RVMDRevolution Medicines$38.33+0.4%2.82%13,69111NTLAIntellia Therapeutics$21.38-3.3%2.80%20,81012INCYIncyte$57.79+0.9%2.77%8,92213ARGXargenx$371.02+2.4%2.76%1,41214EXASExact Sciences$45.45+0.4%2.57%8,80415GILDGilead Sciences$64.27+0.3%2.46%6,86316MREOMereo BioPharma Group$3.45-3.9%2.45%154,79317Chugai Pharmaceutical Co LtdN/A2.40%14,55918CLDXCelldex Therapeutics$33.30-1.0%2.37%12,08519CRSPCRISPR Therapeutics$53.74-0.6%2.29%7,59620GMABGenmab A/S$28.20+0.8%2.24%14,11321BGNEBeiGene$148.85-3.5%2.16%2,55322EXELExelixis$21.69+4.4%2.07%18,77523Siemens Healthineers AG Registered SharesN/A2.00%6,36624DAWNDay One Biopharmaceuticals$13.27-2.4%1.86%24,76125GHGuardant Health$27.10-1.3%1.80%14,77926LNTHLantheus$81.83+1.6%1.75%4,10227LEGNLegend Biotech$40.01-7.7%1.75%8,21528DCPHDeciphera Pharmaceuticals$25.54+0.0%1.69%12,26129First American Treasury Obligs XN/A1.63%301,72430SWTXSpringWorks Therapeutics$41.46-2.7%1.52%6,56031DEPOSITS WITH BROKER FOR SHORT POSITIONSN/A1.51%191,092,07832NUVLNuvalent$65.62-1.3%1.51%4,17733AGIOAgios Pharmaceuticals$36.34-3.2%1.43%8,11434SDGRSchrödinger$21.52-1.2%1.43%12,16335ARVNArvinas$33.14+2.8%1.37%7,17636RCUSArcus Biosciences$15.07+0.9%1.29%14,67837BMYBristol-Myers Squibb$41.09+2.1%1.26%5,62038MRUSMerus$53.24-7.1%1.24%5,19139OPCHOption Care Health$29.82+0.4%1.24%8,00740ACLXArcellx$52.00-0.5%1.09%3,988The Worst is Yet to Come… (Ad)Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now.41IMCRImmunocore$48.98+4.9%1.04%4,00242CGEMCullinan Therapeutics$23.50+3.1%0.93%7,59043IDYAIDEAYA Biosciences$36.55+2.1%0.90%4,32644RLAYRelay Therapeutics$6.41+1.7%0.87%23,11545TXG10x Genomics$22.42+0.0%0.77%6,21046COGTCogent Biosciences$8.01+9.9%0.75%18,57047FATEFate Therapeutics$3.68+6.7%0.37%20,11448PYXSPyxis Oncology$3.74+0.5%0.34%16,47649MRSNMersana Therapeutics$2.33-2.9%0.26%19,75150US DOLLARSN/A-1.44%266,994 Geographic ExposureUnited States79.5%Japan6.7%United Kingdom4.8%Switzerland3.1%Germany2.0%Currency ExposureUSD83.3%JPY6.7%GBP4.8%CHF3.1%EUR2.0%Sector ExposureHealth Care74.1%Consumer Discretionary2.2%Industry ExposureBiotechnology62.1%Health Care Equipment & Supplies8.8%Pharmaceuticals3.1%Diversified Consumer Services2.2%SubIndustry ExposureBiotechnology52.5%Life Sciences Tools & Services5.0%Pharmaceuticals3.9%Health Care Equipment3.8%Coupon Exposure4-61.7%Maturity Exposure15-201.7% Related Companies and Tools Related Companies: ProShares Equities for Rising Rates ETF Portfolio Companies Roundhill Video Games ETF Portfolio Companies Global X Thematic Growth ETF Portfolio Companies Themes Generative Artificial Intelligence ETF Portfolio Companies Horizon Kinetics SPAC Active ETF Portfolio Companies Sprott Energy Transition Materials ETF Portfolio Companies Relative Sentiment Tactical Allocation ETF Portfolio Companies iShares Transition-Enabling Metals ETF Portfolio Companies BNY Mellon Innovators ETF Portfolio Companies iShares Emerging Markets Infrastructure ETF Portfolio Companies This page (NASDAQ:CANC) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
